Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01749332 · ClinicalTrials.gov registry record · NA

A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections

A NA study of Liver Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
117
Enrollment target
1
Study location

NCT01749332 is a NA study of Liver Cancer that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 117 participants, below the 446-participant average among 78 other Liver Cancer trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01749332, a NA study of Liver Cancer, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
117 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to draw blood from vessels near the liver in patients undergoing liver surgery. This will be performed in both patients with cancer in order to learn more about circulating tumor cells, proteins and DNA mutations in the blood. The blood in patients with colorectal cancer with liver metastases will be compared to blood taken from patients that do not have cancer that do not have cancer. Inclusion of patients with benign pathology will allow for the establishment of "normal" values which currently do not exist. We will then study whether tumor mutations can be used to predict recurrence and survival patterns.

Conditions Studied

Interventions

  • OTHER Perihepatic Phlebotomy

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2012-12
Est. Completion 2019-12
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT01749332

The ClinicalTrials.gov registry entry for NCT01749332 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 78 other Liver Cancer trials with a reported enrollment target (74% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Liver Cancer appearing as the primary indexed condition, and to 1 intervention - of which Perihepatic Phlebotomy is the first listed.

NCT01749332 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01749332 about?

NCT01749332 is a clinical study titled "A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections". The purpose of this study is to draw blood from vessels near the liver in patients undergoing liver surgery. This will be performed in both patients with cancer in order to learn more about circulating tumor cells, proteins and DNA mutations in the blood. The blood in patients with colorectal cance...

What is the current status of trial NCT01749332?

This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2012-12. Estimated completion is 2019-12.

What conditions does trial NCT01749332 study?

This clinical trial studies the following conditions: Liver Cancer.

What interventions are being tested in trial NCT01749332?

The interventions under investigation include: Perihepatic Phlebotomy (OTHER).

Who is sponsoring clinical trial NCT01749332?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01749332 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Liver Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.